Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.285 USD -0.31%
Market Cap: 204.1B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbott Laboratories
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Edwards Lifesciences Corp
NYSE:EW
Cash Equivalents
$1.6B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$1.8B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
14%

See Also

What is Abbott Laboratories's Cash Equivalents?
Cash Equivalents
7B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Cash Equivalents amounts to 7B USD.

What is Abbott Laboratories's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
7%

Over the last year, the Cash Equivalents growth was 4%. The average annual Cash Equivalents growth rates for Abbott Laboratories have been -9% over the past three years , 11% over the past five years , and 7% over the past ten years .

Back to Top